Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective

Mohamad Alkhouli, Peter Noseworthy, Charanjit Rihal, David Holmes

Research output: Contribution to journalReview article

15 Scopus citations

Abstract

Ischemic stroke in patients with atrial fibrillation is associated with substantial morbidity and mortality. The growing epidemic of atrial fibrillation worldwide has raised concerns about the dire need for effective stroke prevention systems in these patients. Fortunately, the last decade has witnessed a plethora of data on novel stroke prevention methods in patients with nonvalvular atrial fibrillation. However, optimal selection and effective implementation of these preventative strategies require an integrative approach that takes into account not only the available clinical data but also the perspective of each of the stakeholders involved (patient, physician, and society). The goal of this review was to discuss the contemporary issues surrounding stroke prevention in atrial fibrillation from the perspective of these 3 major stakeholders.

Original languageEnglish (US)
Pages (from-to)2790-2801
Number of pages12
JournalJournal of the American College of Cardiology
Volume71
Issue number24
DOIs
StatePublished - Jun 19 2018

Keywords

  • atrial fibrillation
  • left atrial appendage
  • non–vitamin K antagonist oral anticoagulant
  • oral anticoagulation
  • risk reduction
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective'. Together they form a unique fingerprint.

  • Cite this